Search - tctmd.com

Displaying 121 - 140 of 321

Sort: Relevancy | Date

News Daily News

High Reactivity on Aspirin Just Before PCI Linked to Worse Outcomes

September 02, 2014

News Conference News ESC 2014

SYMPLICITY HTN-3: Renal Denervation Still Safe, Not Effective at 1 Year

Todd Neale

September 01, 2014

News Conference News ESC 2014

NOMI: Nitric Oxide May Do Wonders for STEMI But Not When Mixed with Nitroglycerin

Caitlin E. Cox

September 01, 2014

News Conference News ESC 2014

SOLID-TIMI 52: Darapladib Fails to Reduce Adverse Events After ACS

Yael L. Maxwell

August 31, 2014

News Industry News

Large-scale Study Confirms Growing Body of Clinical Evidence for the St. Jude Medical Quadripolar System

August 31, 2014

News Industry News

Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial

August 30, 2014

News Daily News

Similar Survival Benefits from Surgery, MitraClip in Symptomatic, High-Risk Mitral Regurgitation

L.A. McKeown

August 20, 2014

News Industry News

Novartis to showcase heart failure leadership at ESC Congress 2014 with results on new first of its type medicine LCZ696

August 11, 2014

News Daily News

EVA-3S: Carotid Stenting, Endarterectomy Show Comparable Long-term Efficacy

L.A. McKeown

August 07, 2014

News Daily News

MitraClip Benefits High-, Prohibitive-Risk Patients with Mitral Regurgitation

July 10, 2014

News Features

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

June 24, 2014

News Features

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

June 18, 2014

News Daily News

SYMPLICITY HTN-2: Renal Denervation Safe, Effective at 3 Years

Yael L. Maxwell

June 11, 2014

News Industry News

FDA Approves First Implantable Wireless Device with Remote Monitoring to Measure Pulmonary Artery Pressure in Certain Heart Failure Patients

May 28, 2014

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

News Conference News EuroPCR 2014

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Yael L. Maxwell

May 22, 2014

News Industry News

Preliminary Results From the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective

May 22, 2014

News Conference News EuroPCR 2014

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

Yael L. Maxwell

May 22, 2014

News Daily News

Renal Denervation Shows Promise in Patients Refractory to Stenting

L.A. McKeown

May 02, 2014

News Daily News

Sutureless Valve Shows Encouraging Results in Aortic Stenosis Patients

Yael L. Maxwell

May 01, 2014

Advertisement

High Reactivity on Aspirin Just Before PCI Linked to Worse Outcomes

SYMPLICITY HTN-3: Renal Denervation Still Safe, Not Effective at 1 Year

NOMI: Nitric Oxide May Do Wonders for STEMI But Not When Mixed with Nitroglycerin

SOLID-TIMI 52: Darapladib Fails to Reduce Adverse Events After ACS

Large-scale Study Confirms Growing Body of Clinical Evidence for the St. Jude Medical Quadripolar System

Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial

Similar Survival Benefits from Surgery, MitraClip in Symptomatic, High-Risk Mitral Regurgitation

Novartis to showcase heart failure leadership at ESC Congress 2014 with results on new first of its type medicine LCZ696

EVA-3S: Carotid Stenting, Endarterectomy Show Comparable Long-term Efficacy

MitraClip Benefits High-, Prohibitive-Risk Patients with Mitral Regurgitation

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

SYMPLICITY HTN-2: Renal Denervation Safe, Effective at 3 Years

FDA Approves First Implantable Wireless Device with Remote Monitoring to Measure Pulmonary Artery Pressure in Certain Heart Failure Patients

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Preliminary Results From the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

Renal Denervation Shows Promise in Patients Refractory to Stenting

Sutureless Valve Shows Encouraging Results in Aortic Stenosis Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content